Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Smoking Cessation 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Smoking 1Prostatic Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Oncolytic Virotherapy 2tucatinib 1trifluridine tipiracil drug combination 1tribenoside (combination) 1tribenoside 1trastuzumab deruxtecan 1tipiracil 1sotorasib 1sintilimab 1semaglutide 1regorafenib 1polyethylene glycol 400 1penpulimab 1palbociclib 1montelukast 1encorafenib 1binimetinib 1balstilimab 1adagrasib 1Trifluridine 1Tobacco Use Cessation Devices 1Tablets 1Suppositories 1Standard of Care 1Specimen Handling 1Receptor Protein-Tyrosine Kinases 1Radiosurgery 1Polyethylene Glycols 1Pentoxifylline 1Panitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colorectal Neoplasms × Tobacco Use Cessation Devices × Clear all
NCT01434342 2021-09-28

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
146 enrolled 10 charts
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Tobacco Use Disorder, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡